1746
N. Li et al. / Tetrahedron Letters 54 (2013) 1743–1746
11. Chen, C.; Dagnino, R., Jr.; McCarthy, J. R. J. Org. Chem. 1995, 60, 8428.
S
Ar'
Ar'
12. (a) Liu, C.; Lin, J.; Leftheris, K. Tetrahedron Lett. 2007, 48, 435; (b) Etienne, A.;
Lonchambon, G.; Roques, J.; Rivoallan, J. P. C. R. Acad. Sci., Seri. II 1982, 294,
1183–1186. C. R. Acad. Sci. Seri., II, 1985, 301, 145.
13. Kaila, J. C.; Baraiya, A. B.; Pandya, A. N.; Jalani, H. B.; Sudarsanam, V.; Vasu, K. K.
Tetrahedron Lett. 2010, 51, 1486.
Ar
S
Ar
Ar'
N
H
N
H
NH
Ar
Ar
N
N
C
NH Ar
N
C S
H2N
Base
Addition
N
H
NH
N
Base
H
S
S
Second addition
B
A
1
14. (a) Tietze, L. F. Chem. Rev. 1996, 96, 115; (b) Tietze, L. F.; Brasche, G.; Gerike, K.
Domino Reactions in Organic Chemistry; Wiley-VCH: Weinheim, 2006; (c)
Dömling, A. Chem. Rev. 2006, 106, 17; (d) Zhu, J.; Bienaymé, H. Multicomponent
Reactions; Wiley-VCH: Weinheim, 2005; (e) Döomling, A.; Ugi, I. Angew. Chem.,
Int. Ed. 2000, 39, 3168; (f) Ruijter, E.; Scheffelaar, R.; Orru, R. V. A. Angew. Chem.,
Int. Ed. 2011, 50, 6324; (g) Tietze, L. F.; Kinzel, T.; Brazel, C. C. Acc. Chem. Res.
2009, 42, 367; (h) Groenendaal, B.; Ruijter, E.; Orru, R. V. A. Chem. Commun.
2008, 5474; (i) Ganem, B. Acc. Chem. Res. 2009, 42, 463.
Ar'
Ar'
Base
H
N
N
N
N
Ar
Dethiolation
Cyclization
Ar
N
H
N
S
N
H
N
S
SH
Ar
Ar
3
C
15. (a) Santra, S.; Andreana, P. R. Angew. Chem., Int. Ed. 2011, 50, 9418; (b) Dömling,
A.; Wang, W.; Wang, K. Chem. Rev. 2012, 112, 3083; (c) Fustero, S.; Sánchez-
Roselló, M.; Barrio, P.; Simón-Fuentes, A. Chem. Rev. 2011, 111, 6984; (d) Liao,
L.; Jana, R.; Urkalan, K. B.; Sigman, M. S. J. Am. Chem. Soc. 2011, 133, 5784; (e) Li,
G.; Wei, H. X.; Kim, S. H.; Carducci, M. D. Angew. Chem., Int. Ed. 2001, 40, 4277.
16. (a) Jiang, B.; Yi, M.-S.; Shi, F.; Tu, S.-J.; Pindi, S.; McDowell, P.; Li, G. Chem.
Commun. 2012, 808; (b) Jiang, B.; Li, Q.-Y.; Zhang, H.; Tu, S.-J.; Pindi, S.; Li, G.
Org. Lett. 2012, 14, 700; (c) Jiang, B.; Li, Y.; Tu, M.-S.; Wang, S.-L.; Tu, S.-J.; Li, G.
J. Org. Chem. 2012, 77, 7497; (d) Jiang, B.; Yi, M.-S.; Tu, M.-S.; Wang, S.-L.; Tu, S.-
J. Adv. Synth. Catal. 2012, 354, 2504; (e) Jiang, B.; Tu, S.-J.; Kaur, P.; Wever, W.;
Li, G. J. Am. Chem. Soc. 2009, 131, 11660.
17. (a) Jiang, B.; Zhang, G.; Ma, N.; Shi, F.; Tu, S.-J.; Kaur, P.; Li, G. Org. Biomol. Chem.
2011, 9, 3834; (b) Jiang, B.; Wang, X.; Shi, F.; Tu, S.-J.; Li, G. Org. Biomol. Chem.
2011, 9, 4205; (c) Jiang, B.; Hao, W.-J.; Zhang, J.-P.; Tu, S.-J.; Shi, F. Org. Biomol.
Chem. 2009, 7, 1171; (d) Jiang, B.; Shi, F.; Tu, S.-J. Curr. Org. Chem. 2010, 14, 357;
(e) Jiang, B.; Liu, Y.-P.; Tu, S.-J. Eur. J. Org. Chem. 2011, 3026; (f) Wang, S.-L.; Wu,
F.-Y.; Cheng, C.; Zhang, G.; Liu, Y.-P.; Jiang, B.; Shi, F.; Tu, S.-J. ACS Comb. Sci.
2011, 13, 135.
Scheme 2. The plausible mechanism for the formation of 1,3,5-triazines 3.
Supplementary data
Supplementary data (experimental details and spectroscopic
characterization of all compounds along with 1H, IR and mass
spectra) associated with this article can be found, in the online ver-
References and notes
1. For recent reviews, see: (a) Thomas, G. L.; Johannes, C. W. Curr. Opin. Chem. Biol.
2011, 15, 516; (b) Tohme, R.; Darwiche, N.; Gali-Muhtasib, H. Molecules 2011,
16, 9665; (c) Dandapani, S.; Marcaurelle, L. A. Curr. Opin. Chem. Biol. 2010, 14,
362; (d) Welsch, M. E.; Snyder, S. A.; Stockwell, B. R. Curr. Opin. Chem. Biol. 2010,
14, 347; (e) Carey, J. S.; Laffan, D.; Thomson, C.; Williams, M. T. Org. Biomol.
Chem. 2006, 4, 2337.
2. (a) Garaj, V.; Puccetti, L.; Fasolis, G.; Winum, J. Y.; Montero, J. L.; Scozzafava, A.;
Vullo, D.; Innocenti, A.; Supuran, C. T. Bioorg. Med. Chem. Lett. 2005, 15, 3102;
(b) Saczewski, F.; Brzozowski, Z. Eur. J. Med. Chem. 2002, 37, 709; (c) Saczewski,
F.; Brzozowski, Z.; Gdaniec, M. Eur. J. Med. Chem. 2000, 35, 1053.
3. Whitten, J. P.; Xie, Y. F.; Erickson, P. E.; Webb, T. R.; De Souza, E. B.; Grigoriadis,
D. E.; McCarthy, J. R. J. Med. Chem. 1996, 39, 4354.
18. General procedure for the synthesis of compounds 3: In a 10 mL reaction vial,
benzamidine 2a (1.0 mmol), sodium hydroxide (0.2 mmol) and DMF (2.0 mL)
were mixed and then stirred for 10 min. Subsequently, the 4-chlorophenyl
isothiocyanate 1a (2.2 mmol) was added to the reaction mixture, and the
reaction vial was capped and pre-stirring for 20 s. The mixture was subjected
to microwave irradiation (time: 15 min, temperature: 110 °C; absorption level:
high; fixed hold time). Upon completion, monitored by TLC, the reaction
mixture was cooled to room temperature and was neutralized with 10%
hydrochloric acid. Then, the system was poured into the cool water and was
filtered to give crude product. The crude product was further purified by 95%
EtOH to give the corresponding pure products 3. 6-(4-chlorophenylamino)-1-(4-
chlorophenyl)-4-phenyl-1,3,5-triazine-2(1H)-thione (3a), Yellow solid, Mp 262–
263 °C, 1H NMR (400 MHz, DMSO-d6) d: 9.08 (s, 1H, NH), 8.20 (d, J = 6.8 Hz, 2H,
ArH), 7.67 (d, J = 7.6 Hz, 2H, ArH), 7.68–7.42 (m, 9H, ArH), 13C NMR (100 MHz,
DMSO-d6) d: 185.8, 163.1, 156.2, 137.3, 136.4, 134.0, 131.8, 131.1, 130.7, 130.3,
4. Hasegawa, Y.; Yanagisawa, T.; Okui, Y.; Sato, T.; Hosaka, K.; Chin, M.;
Mitsuhashi, H. Chem. Pharm. Bull. 1991, 39, 3180.
5. Pitts, W. J.; Guo, J.; Dhar, T. G. M.; Shen, Z.; Gu, H.; Watterson, S. H.; Bednarz, M.
S.; Chen, B. C.; Barrish, J. C.; Bassolino, D.; Cheney, D.; Fleener, C. A.; Rouleau, K.
A.; Hollenbaugh, D. L.; Iwanowicz, E. J. Bioorg. Med. Chem. Lett. 2002, 12, 2137.
6. Hajduk, P. J.; Dinges, J.; Schkeryantz, J. M.; Janowick, D.; Kaminski, M.; Tufano,
M.; Augeri, D. J.; Petros, A.; Nienaber, V.; Zhong, P.; Hammond, R.; Coen, M.;
Beutel, B.; Katz, L.; Fesik, S. W. J. Med. Chem. 1999, 42, 3852.
7. Hirt, R.; Nidecker, H.; Berchtold, R. Helv. Chim. Acta 1950, 33, 1365.
8. (a) Yuki, Y.; Sakurai, S.; Kakurai, T.; Noguchi, T. Bull. Chem. Soc. Jpn. 1970, 43,
2130; (b) Shapiro, S. L.; Isaacs, E. S.; Parrino, V. A.; Freedman, L. J. Org. Chem.
1961, 26, 68.
130.1, 129.4, 127.3, 127.0, 125.9. IR (KBr, m
, cmÀ1): 3373, 1593, 1553, 1471,
1429, 1348, 1224, 1091, 1004, 988, 759, 705. HRMS (ESI): m/z calcd for
C
21H13Cl2N4S, 423.0232 [MÀH]À; found: 423.0241.
19. The single-crystal growth was carried out in DMF at room temperature. Crystal
data
for
3l
(CCDC-916140):
C
43H37N11OS2,
crystal
dimension
0.40 Â 0.30 Â 0.21 mm, Monoclinic, space group C2/c, a = 21.438(2) Å,
b = 11.0408(12) Å, c = 19.503(2) Å,
a
=
c
= 90°, b = 121.573(2)°, V = 3933.0(8)
Å3, Mr = 787.96, Z = 4, k = 0.71073 Å,
R1 = 0.0423, wR2 = 0.0925.
l(Mo K
a
) = 0.186 mmÀ1, F(000) = 1648,
9. Alkalay, D.; Volk, J.; Bartlett, M. F. J. Pharm. Sci. 1976, 65, 525.
10. Irikura, T.; Abe, Y.; Okamura, K.; Higo, K.; Maeda, A.; Morinaga, F.; Shirai, G.;
Hatae, S. J. Med. Chem. 1970, 13, 1081.